Cargando…

Budget Impact Analysis of Molecular Lymph Node Staging Versus Conventional Histopathology Staging in Colorectal Carcinoma

BACKGROUND: The presence of lymph node (LN) metastasis is a critical prognostic factor in colorectal cancer (CRC) patients and is also an indicator for adjuvant chemotherapy. The gold standard (GS) technique for LN diagnosis and staging is based on the analysis of haematoxylin and eosin (H&E)-st...

Descripción completa

Detalles Bibliográficos
Autores principales: Diaz-Mercedes, Sherley, Archilla, Ivan, Camps, Jordi, de Lacy, Antonio, Gorostiaga, Iñigo, Momblan, Dulce, Ibarzabal, Ainitze, Maurel, Joan, Chic, Nuria, Bombí, Josep Antoni, Balaguer, Francesc, Castells, Antoni, Aldecoa, Iban, Borras, Josep Maria, Cuatrecasas, Miriam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748889/
https://www.ncbi.nlm.nih.gov/pubmed/31115896
http://dx.doi.org/10.1007/s40258-019-00482-7
_version_ 1783452158485594112
author Diaz-Mercedes, Sherley
Archilla, Ivan
Camps, Jordi
de Lacy, Antonio
Gorostiaga, Iñigo
Momblan, Dulce
Ibarzabal, Ainitze
Maurel, Joan
Chic, Nuria
Bombí, Josep Antoni
Balaguer, Francesc
Castells, Antoni
Aldecoa, Iban
Borras, Josep Maria
Cuatrecasas, Miriam
author_facet Diaz-Mercedes, Sherley
Archilla, Ivan
Camps, Jordi
de Lacy, Antonio
Gorostiaga, Iñigo
Momblan, Dulce
Ibarzabal, Ainitze
Maurel, Joan
Chic, Nuria
Bombí, Josep Antoni
Balaguer, Francesc
Castells, Antoni
Aldecoa, Iban
Borras, Josep Maria
Cuatrecasas, Miriam
author_sort Diaz-Mercedes, Sherley
collection PubMed
description BACKGROUND: The presence of lymph node (LN) metastasis is a critical prognostic factor in colorectal cancer (CRC) patients and is also an indicator for adjuvant chemotherapy. The gold standard (GS) technique for LN diagnosis and staging is based on the analysis of haematoxylin and eosin (H&E)-stained slides, but its sensitivity is low. As a result, patients may not be properly diagnosed and some may have local recurrence or distant metastases after curative-intent surgery. Many of these diagnostic and treatment problems could be avoided if the one-step nucleic acid amplification assay (OSNA) was used rather than the GS technique. OSNA is a fast, automated, standardised, highly sensitive, quantitative technique for detecting LN metastases. OBJECTIVES: The aim of this study was to assess the budget impact of introducing OSNA LN analysis in early-stage CRC patients in the Spanish National Health System (NHS). METHODS: A budget impact analysis comparing two scenarios (GS vs. OSNA) was developed within the Spanish NHS framework over a 3-year time frame (2017–2019). The patient population consisted of newly diagnosed CRC patients undergoing surgical treatment, and the following costs were included: initial surgery, pathological diagnosis, staging, follow-up expenses, systemic treatment and surgery after recurrence. One- and two-way sensitivity analyses were performed. RESULTS: Using OSNA instead of the GS would have saved €1,509,182, €6,854,501 and €10,814,082 during the first, second and third years of the analysis, respectively, because patients incur additional costs in later years, leading to savings of more than €19 million for the NHS over the 3-year time horizon. CONCLUSIONS: Introducing OSNA in CRC LN analysis may represent not only an economic benefit for the NHS but also a clinical benefit for CRC patients since a more accurate staging could be performed, thus avoiding unnecessary treatments. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s40258-019-00482-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6748889
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-67488892019-10-01 Budget Impact Analysis of Molecular Lymph Node Staging Versus Conventional Histopathology Staging in Colorectal Carcinoma Diaz-Mercedes, Sherley Archilla, Ivan Camps, Jordi de Lacy, Antonio Gorostiaga, Iñigo Momblan, Dulce Ibarzabal, Ainitze Maurel, Joan Chic, Nuria Bombí, Josep Antoni Balaguer, Francesc Castells, Antoni Aldecoa, Iban Borras, Josep Maria Cuatrecasas, Miriam Appl Health Econ Health Policy Original Research Article BACKGROUND: The presence of lymph node (LN) metastasis is a critical prognostic factor in colorectal cancer (CRC) patients and is also an indicator for adjuvant chemotherapy. The gold standard (GS) technique for LN diagnosis and staging is based on the analysis of haematoxylin and eosin (H&E)-stained slides, but its sensitivity is low. As a result, patients may not be properly diagnosed and some may have local recurrence or distant metastases after curative-intent surgery. Many of these diagnostic and treatment problems could be avoided if the one-step nucleic acid amplification assay (OSNA) was used rather than the GS technique. OSNA is a fast, automated, standardised, highly sensitive, quantitative technique for detecting LN metastases. OBJECTIVES: The aim of this study was to assess the budget impact of introducing OSNA LN analysis in early-stage CRC patients in the Spanish National Health System (NHS). METHODS: A budget impact analysis comparing two scenarios (GS vs. OSNA) was developed within the Spanish NHS framework over a 3-year time frame (2017–2019). The patient population consisted of newly diagnosed CRC patients undergoing surgical treatment, and the following costs were included: initial surgery, pathological diagnosis, staging, follow-up expenses, systemic treatment and surgery after recurrence. One- and two-way sensitivity analyses were performed. RESULTS: Using OSNA instead of the GS would have saved €1,509,182, €6,854,501 and €10,814,082 during the first, second and third years of the analysis, respectively, because patients incur additional costs in later years, leading to savings of more than €19 million for the NHS over the 3-year time horizon. CONCLUSIONS: Introducing OSNA in CRC LN analysis may represent not only an economic benefit for the NHS but also a clinical benefit for CRC patients since a more accurate staging could be performed, thus avoiding unnecessary treatments. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s40258-019-00482-7) contains supplementary material, which is available to authorized users. Springer International Publishing 2019-05-21 2019 /pmc/articles/PMC6748889/ /pubmed/31115896 http://dx.doi.org/10.1007/s40258-019-00482-7 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Research Article
Diaz-Mercedes, Sherley
Archilla, Ivan
Camps, Jordi
de Lacy, Antonio
Gorostiaga, Iñigo
Momblan, Dulce
Ibarzabal, Ainitze
Maurel, Joan
Chic, Nuria
Bombí, Josep Antoni
Balaguer, Francesc
Castells, Antoni
Aldecoa, Iban
Borras, Josep Maria
Cuatrecasas, Miriam
Budget Impact Analysis of Molecular Lymph Node Staging Versus Conventional Histopathology Staging in Colorectal Carcinoma
title Budget Impact Analysis of Molecular Lymph Node Staging Versus Conventional Histopathology Staging in Colorectal Carcinoma
title_full Budget Impact Analysis of Molecular Lymph Node Staging Versus Conventional Histopathology Staging in Colorectal Carcinoma
title_fullStr Budget Impact Analysis of Molecular Lymph Node Staging Versus Conventional Histopathology Staging in Colorectal Carcinoma
title_full_unstemmed Budget Impact Analysis of Molecular Lymph Node Staging Versus Conventional Histopathology Staging in Colorectal Carcinoma
title_short Budget Impact Analysis of Molecular Lymph Node Staging Versus Conventional Histopathology Staging in Colorectal Carcinoma
title_sort budget impact analysis of molecular lymph node staging versus conventional histopathology staging in colorectal carcinoma
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748889/
https://www.ncbi.nlm.nih.gov/pubmed/31115896
http://dx.doi.org/10.1007/s40258-019-00482-7
work_keys_str_mv AT diazmercedessherley budgetimpactanalysisofmolecularlymphnodestagingversusconventionalhistopathologystagingincolorectalcarcinoma
AT archillaivan budgetimpactanalysisofmolecularlymphnodestagingversusconventionalhistopathologystagingincolorectalcarcinoma
AT campsjordi budgetimpactanalysisofmolecularlymphnodestagingversusconventionalhistopathologystagingincolorectalcarcinoma
AT delacyantonio budgetimpactanalysisofmolecularlymphnodestagingversusconventionalhistopathologystagingincolorectalcarcinoma
AT gorostiagainigo budgetimpactanalysisofmolecularlymphnodestagingversusconventionalhistopathologystagingincolorectalcarcinoma
AT momblandulce budgetimpactanalysisofmolecularlymphnodestagingversusconventionalhistopathologystagingincolorectalcarcinoma
AT ibarzabalainitze budgetimpactanalysisofmolecularlymphnodestagingversusconventionalhistopathologystagingincolorectalcarcinoma
AT maureljoan budgetimpactanalysisofmolecularlymphnodestagingversusconventionalhistopathologystagingincolorectalcarcinoma
AT chicnuria budgetimpactanalysisofmolecularlymphnodestagingversusconventionalhistopathologystagingincolorectalcarcinoma
AT bombijosepantoni budgetimpactanalysisofmolecularlymphnodestagingversusconventionalhistopathologystagingincolorectalcarcinoma
AT balaguerfrancesc budgetimpactanalysisofmolecularlymphnodestagingversusconventionalhistopathologystagingincolorectalcarcinoma
AT castellsantoni budgetimpactanalysisofmolecularlymphnodestagingversusconventionalhistopathologystagingincolorectalcarcinoma
AT aldecoaiban budgetimpactanalysisofmolecularlymphnodestagingversusconventionalhistopathologystagingincolorectalcarcinoma
AT borrasjosepmaria budgetimpactanalysisofmolecularlymphnodestagingversusconventionalhistopathologystagingincolorectalcarcinoma
AT cuatrecasasmiriam budgetimpactanalysisofmolecularlymphnodestagingversusconventionalhistopathologystagingincolorectalcarcinoma